KAYLA SMITH: Open Payments
NPI 1831721018 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,602 in 98 payments from 40 companies in 2025. Trend: 2023 $2,411 · 2024 $2,636 · 2025 $2,602
Food & beverage: $2,602
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $356 |
| ABBVIE INC. | 7 | $243 |
| Gilead Sciences, Inc. | 5 | $170 |
| Daiichi Sankyo Inc. | 7 | $170 |
| Novartis Pharmaceuticals Corporation | 7 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $156 |
| BeOne Medicines USA, Inc. | 4 | $143 |
| Janssen Biotech, Inc. | 6 | $121 |
| Merck Sharp & Dohme LLC | 6 | $120 |
| Geron Corporation | 2 | $74 |
Products named: VENCLEXTA, Trodelvy, Enhertu, DATROWAY, LIBTAYO, IMFINZI, KEYTRUDA, TEVIMBRA.
Industry payments across KY — which companies pay providers there.
